Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 365 of 1,261
  1. US 10918738

    Method of treating type I diabetes using an AAV vector encoding uracortin 2

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  2. US 10919869

    Thiazole derivative and applications

    East China University of Science and Technology · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  3. US 10918653

    Bovine milk oligosaccharides

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  4. US 10919951

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  5. US 10919932

    Bi-terminal pegylated integrin-binding peptides and methods of use thereof

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  6. US 10919891

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  7. US 10920190

    Folding biological tissue via programmed cellular contractility

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  8. US 10919019

    Apparatus for the synthesis of radiopharmaceutical products

    Ion Beam Applications · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  9. US 10918732

    Glycoconjugates and methods for their use

    The Board of Regents of the University of Texas System · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  10. US 10920223

    Serpina1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  11. US 10920227

    Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  12. US 10918666

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  13. US 10918703

    Fusion proteins for treating inflammatory diseases

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  14. US 10918691

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  15. US 10918673

    Immunoisolation device

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  16. US 10918648

    Estrogen receptor modulator combinations

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  17. US 10918598

    On demand vesicle formation from vesicle precursors suitable for long-term storage

    The Regents of the University of California · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  18. US 10920020

    3D-printing of ultra-high refractive index polymers

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  19. US 10919939

    Mu opioid receptor agonist analogs of the endomorphins

    United States Department of Veteran Affairs · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  20. US 10919937

    Bicyclic peptide ligands and uses thereof

    BicycleTx Limited · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  21. AU 2019294474

    Pyridine derivatives substituted by heterocyclic ring and amino group

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Feb 11, 2021 · Expires Feb 6, 2041

    granted
  22. US 2021038684

    Compositions and Methods for Cancer Immunotherapy

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 11, 2021 · Expires Feb 6, 2041

    granted
  23. US 10912791

    Compositions comprising antisense-encoded erythropoietin receptor and use thereof

    The Board of Regents of the University of Texas System · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  24. US 10912933

    Implants for localized drug delivery and methods of use thereof

    The Regents of the University of California · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.